Among modern cancer therapies, immune checkpoint inhibitors (ICI) are among the most successful treatment methods. These ...

UCLA researchers have developed a new kind of immunotherapy that uses specially engineered immune cells equipped with built-in weapons to attack kidney cancer tumors and reprogram their protective ...

AlloCAR70-NKT is an off-the-shelf immunotherapy using engineered immune cells to target kidney cancer without patient-specific customization. The therapy addresses challenges of traditional CAR-T ...

New research from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and U.S. Department of Veterans Affairs has identified the molecular mechanism that causes kidney ...

The first cancer patient Nick Salgia saw during his gap year working at an oncology research center had a rare and hyper-aggressive subtype of kidney cancer. Fortunately, a novel immunotherapy had ...

UCLA researchers have developed a new kind of immunotherapy that uses specially engineered immune cells equipped with built-in weapons to attack kidney cancer tumors and reprogram their protective ...

New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...

If you have metastatic bladder cancer, you may also be at higher risk for kidney problems, including acute kidney injuries ...